Abstract
If more than 30% of cancers occur at present in France among elderly people, it is estimated that this proportion will reach 50–60% within the next two or three decades. To deal with and anticipate this challenge, successive national Cancer Control Plans have included specific actions on the organization of the treatment of elderly cancer patients. The organizational framework is based on an oncologist-geriatrician partnership at the head of oncogeriatrics coordination units. After a pilot phase conducted in 15 health care institutions, it has been deployed in 22 regions of mainland France and in one overseas territory. These units are mainly intended to ensure that each patient will receive a cancer treatment adapted to his overall health and not only related to his age. This organization evolves with both the evolution of the health landscape (in accordance with the modernization law of the health system of 26 January 2016), and the territorial reform that identifies13 regions in mainland France and five regions in overseas. It also has to take into account not only the therapeutic initial decision but also the patient’s pathway and his quality of life during and after the cancer treatment. His adaptation is essential to fully optimize the treatment of these elderly people suffering from cancer who will shortly represent the vast majority of people with cancer.
References
Anhoury P, Pickhaert A-P, Ramsey B, Gochenauer G, Lifschitz S. The European oncologist approach to geriatric patients (Abstract). Crit Rev Oncol/Hematol. 2009;72(Suppl 1):S19.
Caillet P, Canoui-Poitrine F, Vouriot J, Berle M, Reinald N, Krypciak S, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol. 2011;29(27):3636–42.
Canouï-Poitrine F, Reinald N, Laurent M, Guery E, Caillet P, David JP, ELCAPA Study Group, et al. Geriatric assessment findings independently associated with clinical depression in 1902 older patients with cancer: the ELCAPA cohort study. Psychooncology. 2016;25:104–11.
Chaïbi P, Magné N, Breton S, Chebib A, Watson S, Duron J-J, et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol. 2011;79(3):302–7.
Chicoulaa B, Balardy L, Stillmunkes A, Mourey L, Oustric S, Rouge Bugat ME. French general practitioners’sense of isolation in the management of elderly cancer patients. Fam Pract. 2016;33(5):551–6.
Corre R, Greiller L, Le Caër H, Audigier-Valette C, Baize N, Bérard H, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study. J Clin Oncol. 2016;34(13):1476–83.
Estimation de la prévalence (partielle et totale) du cancer en France métropolitaine chez les 15 ans et plus en 2008 – Étude à partir des registres des cancers du réseau Francim; Format : Brochure A4; Auteurs: Colonna M, Mitton N, Grosclaude P.; Date de publication : juillet 2014; ISBN : 978-2-37219-022-0; ISBN net : 978-2-37219-023-7; http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Estimation-de-la-prevalence-partielle-et-totale-du-cancer-en-France-metropolitaine-chez-les-15-ans-et-plus-en-2008 (2008). Accessed 25 Nov 2016.
Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25(14):1824–31.
Farcet F, de Decker L, Pauly V, Rousseau F, Bergman H, Molines C, et al. Frailty markers and treatment decisions in patients seen in oncogeriatrics clinics : results from the ASRO pilot study. PLoS One. 2016;11(2):e0149732.
Ferrat E, Paillaud E, Laurent M, Le Thuaut A, Caillet P, Tournigand C, ELCAPA Study Group, et al. Predictors of 1-year mortality in a prospective cohort of elderly patients with cancer. J Gerontol A Biol Sci Med Sci. 2015;70(9):1148–55.
Ferrat E, Audureau E, Paillaud E, Liuu E, Tournigand C, Lagrange JL, ELCAPA Study Group, et al. Four distinct health profiles in older patients with cancer: latent class analysis of the prospective ELCAPA cohort. J Gerontol A Biol Sci Med Sci. 2016;71(12):1653–60. pii:glw052
Hoppe S, Rainfray M, Fonck M, Hoppenreys L, Blanc J-F, Ceccaldi J, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol. 2013;31(31):3877–82.
Hurria A, Dale W, Mooney M, Rowland JH, Ballman KV, Cohen HJ, et al. Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol. 2014;32(24):2587–94.
Kelly CM, Power DG, Lichtman SM. Targeted therapy in older patients with solid tumors. J Clin Oncol. 2014;32(24):2635–46.
Kurtz J-E, Heitz D, Enderlin P, Imbert F, Nehme H, Bergerat J-P, Dufour P. Geriatric oncology, general practitioners and specialists: current opinions and unmet needs. Crit Rev Oncol/Hematol. 2010;75(1):47–57.
Landre T, Uzzan B, Nicolas P, Aparicio T, Zelek L, Mary F, et al. Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. A meta-analysis. Int J Color Dis. 2015;30(10):1305–10.
Lange M, Heutte N, Rigal O, Noal S, Kurtz JE, Levy C, et al. Decline in cognitive function in older adults with early-stage breast cancer after adjuvant treatment. Oncologist. 2016; doi:10.1634/theoncologist.2016-0014.
Laurent M, des Guetz G, Batstuji-Garin S, Culine S, Caillet P, Aparicio T, et al. Chronological age and risk of chemotherapy non-feasibility : a real-life cohort study of 153 stage II or III colorectal cancer patients given adjuvant-modified FOLFOX6. Am J Clin Oncol. 2015; doi:10.1097/COC.0000000000000233.
Les Cancers en France. Type de document: Etude/Rapport; Auteurs: Natalie Vongmany, Philippe-Jean Bousquet; Editeur: Boulogne Billancourt [France] : INCa (Institut National du Cancer); Année de publication: 2016/04; Importance: 236p.; ISBN/ISSN/EAN : 978-2-37219-201-9; http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Les-cancers-en-France-Edition-2015 (2015). Accessed 25 Nov 2016.
Magnuson A, Dale W, Mohile S. Models of care in geriatric oncology. Curr Geriatr Resp. 2014;3(3):182–9.
Mandelblatt JS, Jacobsen PB, Ahles T. Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. J Clin Oncol. 2014;32(24):2617–26.
McCleary NJ, Wigler D, Berry D, Sato K, Abrams T, Chan J, et al. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013;18(1):64–72.
Mohile SG, Hurria A, Cohen HJ, Rowland JH, Leach CR, Arora NK, et al. Improving the quality of survivorship for older adults with cancer. Cancer. 2016;122(16):2459–68.
Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33(13):1453–9.
Oziel-Taieb S, Faure M, Gilabert M, Autret A, Turrini O, Moureau-Zabotto L, et al. Treatment of pancreatic adenocarcinoma in elderly patients over 75 years of age: a retrospective series of 129 patients. J Gastrointes Cancer. 2016;47(1):15–9.
Pamoukdjian F, Paillaud E, Zelek L, Laurent M, Lévy V, Landre T, et al. Measurement of gait speed in older adults to identify complications associated with frailty : a systematic review. J Geriatr Oncol. 2015;6(6):484–96.
Petit-Monéger A, Rainfray M, Soubeyran P, Bellera CA, Mathoulin-Pélissier S. Detection of frailty in elderly cancer patients: improvement of the G8 screening test. J Geriatric Oncol. 2016;7(2):99–107.
Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2015 - Rapport technique; Format : Affichette; Date de publication : novembre 2015; Auteurs: Leone N, Voirin N, Roche L, Binder-Foucard F, Woronoff AS, Delafosse P, et al.; ISBN-NET : 979–10–289-0153-0, ISSN: 1956–6964; http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Projection-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-metropolitaine-en-2015-Rapport-technique (2015). Accessed 25 Nov 2016.
Rivera C, Dahan M, Bernard A, Falcoz P-E, Thomas P. Surgical treatment of lung cancer in the octogenerians: results of a nationwide audit. Eur J Cardiothorac Surg. 2011;39(6):981–6.
Rivoirard R, Chargari C, Kullab S, Trone J-C, Langrand-Escure J, Moriceau G, et al. Chemotherapy regimen in nonagenarian cancer patients: a bi-institutional experience. Chemotherapy. 2016;61(2):65–71.
Sabatier R, Calderon B Jr, Lambaudie E, Chereau E, Provansal M, Cappiello MA, et al. Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study. Int J Gynecol Cancer. 2015;25(5):815–22.
Scher KS, Hurria A. Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol. 2012;30(17):2036–8.
Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy. The process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.
Soubeyran P, Bellera C, Goyard J, Heitz D, Cure H, Rousselot H, et al. Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS One. 2014;9(12):e 115060.
Wildiers H, Mauer M, Pallis A, Hurria A, Mohile SG, Luciani A, et al. End points and trial design in geriatric oncology research: a joint European organization for research and treatment of cancer - alliance for clinical trials in oncology – international society of geriatric oncology position article. J Clin Oncol. 2013;31(29):3711–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Bréchot, JM., Bousquet, PJ., Ferrari, C., Viguier, J., Ifrah, N. (2017). Integrating Geriatric Oncology in Public Health Planning. In: Extermann, M. (eds) Geriatric Oncology . Springer, Cham. https://doi.org/10.1007/978-3-319-44870-1_91-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-44870-1_91-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44870-1
Online ISBN: 978-3-319-44870-1
eBook Packages: Springer Reference MedicineReference Module Medicine